| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardium | 31 | 2024 | 4765 | 3.190 |
Why?
|
| Diffusion Tensor Imaging | 13 | 2022 | 2421 | 1.970 |
Why?
|
| Heart | 24 | 2023 | 4429 | 1.860 |
Why?
|
| Myocardial Infarction | 27 | 2024 | 11513 | 1.540 |
Why?
|
| Fluorescent Dyes | 11 | 2024 | 1928 | 1.490 |
Why?
|
| Magnetic Resonance Imaging | 47 | 2023 | 36582 | 1.350 |
Why?
|
| Myofibrils | 4 | 2016 | 143 | 1.300 |
Why?
|
| Adipose Tissue, Brown | 4 | 2020 | 776 | 1.270 |
Why?
|
| Carbocyanines | 5 | 2022 | 177 | 1.270 |
Why?
|
| Annexin A5 | 6 | 2015 | 102 | 1.200 |
Why?
|
| Magnetic Resonance Imaging, Cine | 6 | 2020 | 1092 | 1.160 |
Why?
|
| Nanoparticles | 16 | 2022 | 1966 | 1.150 |
Why?
|
| Molecular Imaging | 6 | 2020 | 822 | 1.120 |
Why?
|
| Myocytes, Cardiac | 14 | 2019 | 1672 | 1.090 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 8 | 2023 | 2811 | 1.070 |
Why?
|
| Gadolinium DTPA | 4 | 2017 | 823 | 0.990 |
Why?
|
| Contrast Media | 17 | 2017 | 5329 | 0.960 |
Why?
|
| Ventricular Remodeling | 11 | 2019 | 1281 | 0.930 |
Why?
|
| Myocardial Reperfusion Injury | 4 | 2017 | 483 | 0.900 |
Why?
|
| Cardiac Imaging Techniques | 2 | 2016 | 280 | 0.860 |
Why?
|
| Magnetics | 7 | 2012 | 586 | 0.850 |
Why?
|
| Positron-Emission Tomography | 11 | 2024 | 6550 | 0.840 |
Why?
|
| Collagen | 4 | 2024 | 2636 | 0.830 |
Why?
|
| Regeneration | 3 | 2024 | 1523 | 0.800 |
Why?
|
| Atherosclerosis | 10 | 2020 | 3418 | 0.750 |
Why?
|
| Apoptosis | 16 | 2018 | 9513 | 0.750 |
Why?
|
| Annexins | 2 | 2011 | 40 | 0.720 |
Why?
|
| Autophagy | 2 | 2022 | 1347 | 0.700 |
Why?
|
| Magnetite Nanoparticles | 5 | 2014 | 310 | 0.670 |
Why?
|
| Myocardial Ischemia | 5 | 2015 | 2131 | 0.660 |
Why?
|
| Molecular Probe Techniques | 4 | 2013 | 111 | 0.640 |
Why?
|
| Microscopy, Fluorescence | 11 | 2020 | 2628 | 0.640 |
Why?
|
| Dextrans | 5 | 2017 | 574 | 0.610 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2022 | 749 | 0.610 |
Why?
|
| Oxidation-Reduction | 1 | 2024 | 2221 | 0.590 |
Why?
|
| Magnetic Resonance Angiography | 7 | 2020 | 1429 | 0.580 |
Why?
|
| Heart Ventricles | 6 | 2023 | 3837 | 0.580 |
Why?
|
| Atrial Appendage | 1 | 2021 | 285 | 0.580 |
Why?
|
| Image Enhancement | 8 | 2015 | 2867 | 0.570 |
Why?
|
| Animals | 84 | 2024 | 168965 | 0.550 |
Why?
|
| Cicatrix | 2 | 2024 | 798 | 0.540 |
Why?
|
| Cytoprotection | 1 | 2017 | 199 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 33 | 2024 | 22361 | 0.520 |
Why?
|
| Mice | 50 | 2024 | 81912 | 0.470 |
Why?
|
| Nucleic Acids | 1 | 2017 | 189 | 0.450 |
Why?
|
| Tomography, Optical | 4 | 2008 | 129 | 0.450 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2018 | 1549 | 0.450 |
Why?
|
| Zebrafish | 3 | 2024 | 3036 | 0.440 |
Why?
|
| Nanostructures | 2 | 2017 | 549 | 0.430 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2019 | 856 | 0.430 |
Why?
|
| Necrosis | 5 | 2015 | 1614 | 0.430 |
Why?
|
| Organometallic Compounds | 3 | 2017 | 648 | 0.430 |
Why?
|
| Aortic Valve Stenosis | 3 | 2023 | 2021 | 0.420 |
Why?
|
| Cardiovascular Diseases | 10 | 2022 | 15645 | 0.420 |
Why?
|
| Cell Death | 4 | 2015 | 1677 | 0.410 |
Why?
|
| Liposomes | 2 | 2017 | 787 | 0.410 |
Why?
|
| Diagnostic Imaging | 6 | 2015 | 3530 | 0.410 |
Why?
|
| Nanotechnology | 5 | 2013 | 702 | 0.410 |
Why?
|
| Triiodobenzoic Acids | 1 | 2012 | 124 | 0.400 |
Why?
|
| Cardiovascular System | 1 | 2020 | 839 | 0.400 |
Why?
|
| Macrophages | 10 | 2018 | 5785 | 0.400 |
Why?
|
| Heart Diseases | 2 | 2018 | 2817 | 0.400 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 3 | 2014 | 692 | 0.390 |
Why?
|
| Respiration | 3 | 2020 | 1655 | 0.390 |
Why?
|
| Metal Nanoparticles | 3 | 2015 | 400 | 0.390 |
Why?
|
| Monocytes | 5 | 2018 | 2598 | 0.380 |
Why?
|
| Doxorubicin | 4 | 2022 | 2229 | 0.380 |
Why?
|
| Image Processing, Computer-Assisted | 12 | 2019 | 8940 | 0.370 |
Why?
|
| Disease Models, Animal | 18 | 2024 | 18330 | 0.360 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 5 | 2013 | 1142 | 0.350 |
Why?
|
| Tomography | 1 | 2013 | 443 | 0.350 |
Why?
|
| Fibrin | 2 | 2024 | 514 | 0.350 |
Why?
|
| Microbubbles | 1 | 2011 | 137 | 0.350 |
Why?
|
| Protective Agents | 1 | 2011 | 150 | 0.350 |
Why?
|
| 4-Chloro-7-nitrobenzofurazan | 1 | 2009 | 21 | 0.340 |
Why?
|
| Pentetic Acid | 1 | 2009 | 209 | 0.330 |
Why?
|
| Oxygen | 3 | 2020 | 4252 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 7 | 2020 | 4052 | 0.300 |
Why?
|
| Coronary Vessels | 4 | 2013 | 3114 | 0.300 |
Why?
|
| Energy Transfer | 1 | 2008 | 108 | 0.300 |
Why?
|
| Sheep | 4 | 2012 | 1449 | 0.290 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2016 | 3370 | 0.290 |
Why?
|
| Thrombosis | 1 | 2021 | 2954 | 0.290 |
Why?
|
| Spin Labels | 2 | 2008 | 334 | 0.280 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1804 | 0.280 |
Why?
|
| Cathepsins | 2 | 2022 | 243 | 0.280 |
Why?
|
| Khellin | 2 | 2018 | 5 | 0.270 |
Why?
|
| Microspheres | 3 | 2013 | 774 | 0.270 |
Why?
|
| Cardiovascular Agents | 1 | 2013 | 849 | 0.270 |
Why?
|
| Magnetic Resonance Spectroscopy | 5 | 2021 | 3684 | 0.270 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2710 | 0.260 |
Why?
|
| Sirolimus | 1 | 2013 | 1539 | 0.250 |
Why?
|
| Tomography, Optical Coherence | 2 | 2016 | 2954 | 0.250 |
Why?
|
| Aortic Diseases | 1 | 2011 | 741 | 0.250 |
Why?
|
| Phenotype | 3 | 2020 | 16718 | 0.240 |
Why?
|
| Myocarditis | 1 | 2012 | 802 | 0.240 |
Why?
|
| Cardiomyopathies | 4 | 2020 | 2057 | 0.240 |
Why?
|
| Predictive Value of Tests | 9 | 2021 | 15424 | 0.230 |
Why?
|
| Ferrosoferric Oxide | 7 | 2015 | 348 | 0.230 |
Why?
|
| Anisotropy | 5 | 2022 | 1289 | 0.220 |
Why?
|
| Fluorescence | 2 | 2012 | 751 | 0.220 |
Why?
|
| Heart Failure | 7 | 2020 | 11877 | 0.210 |
Why?
|
| Humans | 64 | 2024 | 767040 | 0.200 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2003 | 234 | 0.200 |
Why?
|
| Electromagnetic Phenomena | 1 | 2023 | 159 | 0.200 |
Why?
|
| Echocardiography | 4 | 2019 | 5042 | 0.200 |
Why?
|
| Radial Artery | 1 | 2003 | 187 | 0.200 |
Why?
|
| Half-Life | 2 | 2020 | 648 | 0.190 |
Why?
|
| DNA | 6 | 2013 | 7210 | 0.190 |
Why?
|
| Gadolinium | 5 | 2013 | 964 | 0.190 |
Why?
|
| Coronary Circulation | 4 | 2009 | 1603 | 0.190 |
Why?
|
| Macrolides | 1 | 2022 | 204 | 0.180 |
Why?
|
| Albumins | 1 | 2003 | 577 | 0.180 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2015 | 610 | 0.180 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 2028 | 0.170 |
Why?
|
| Dioxoles | 1 | 2020 | 96 | 0.170 |
Why?
|
| Reproducibility of Results | 12 | 2022 | 20169 | 0.170 |
Why?
|
| Phantoms, Imaging | 7 | 2022 | 2487 | 0.160 |
Why?
|
| Echo-Planar Imaging | 2 | 2021 | 648 | 0.160 |
Why?
|
| Coronary Thrombosis | 1 | 2002 | 440 | 0.160 |
Why?
|
| Analysis of Variance | 5 | 2015 | 6215 | 0.160 |
Why?
|
| Ventricular Function, Left | 5 | 2014 | 3934 | 0.160 |
Why?
|
| Sensitivity and Specificity | 9 | 2015 | 14672 | 0.160 |
Why?
|
| Coronary Artery Disease | 2 | 2013 | 6573 | 0.160 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 393 | 0.150 |
Why?
|
| Arginine | 1 | 2022 | 931 | 0.150 |
Why?
|
| Permeability | 2 | 2018 | 721 | 0.150 |
Why?
|
| Ventricular Pressure | 1 | 2019 | 210 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2003 | 501 | 0.150 |
Why?
|
| Sheep, Domestic | 1 | 2018 | 52 | 0.150 |
Why?
|
| Injections, Intravenous | 1 | 2020 | 1377 | 0.150 |
Why?
|
| Diastole | 2 | 2018 | 784 | 0.150 |
Why?
|
| Aortic Valve | 2 | 2023 | 1968 | 0.140 |
Why?
|
| Molecular Biology | 3 | 2011 | 573 | 0.140 |
Why?
|
| Motion | 4 | 2023 | 784 | 0.140 |
Why?
|
| Epoxide Hydrolases | 1 | 2018 | 122 | 0.140 |
Why?
|
| Infarction | 1 | 2018 | 247 | 0.140 |
Why?
|
| Fetal Heart | 1 | 2018 | 281 | 0.140 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2702 | 0.140 |
Why?
|
| Endocardium | 1 | 2018 | 249 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 20741 | 0.130 |
Why?
|
| Statistics, Nonparametric | 3 | 2015 | 2850 | 0.130 |
Why?
|
| Rabbits | 4 | 2018 | 4751 | 0.130 |
Why?
|
| Leigh Disease | 1 | 2017 | 89 | 0.130 |
Why?
|
| Microscopy, Confocal | 2 | 2013 | 1969 | 0.130 |
Why?
|
| Electron Transport Complex I | 1 | 2017 | 152 | 0.130 |
Why?
|
| Benzothiazoles | 1 | 2017 | 244 | 0.130 |
Why?
|
| Peptide Hydrolases | 3 | 2008 | 610 | 0.130 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2018 | 737 | 0.130 |
Why?
|
| Factor XIII | 4 | 2008 | 59 | 0.120 |
Why?
|
| Iron | 2 | 2018 | 1811 | 0.120 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2013 | 694 | 0.120 |
Why?
|
| Equipment Design | 4 | 2021 | 3489 | 0.120 |
Why?
|
| Rats | 4 | 2020 | 23713 | 0.120 |
Why?
|
| Carotid Arteries | 2 | 2014 | 934 | 0.120 |
Why?
|
| Models, Animal | 3 | 2018 | 2121 | 0.120 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 347 | 0.120 |
Why?
|
| Malate Dehydrogenase | 1 | 2014 | 40 | 0.120 |
Why?
|
| Zirconium | 1 | 2015 | 109 | 0.120 |
Why?
|
| Manganese | 1 | 2017 | 393 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 6067 | 0.120 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 1481 | 0.110 |
Why?
|
| Catecholamines | 1 | 2015 | 388 | 0.110 |
Why?
|
| Molecular Probes | 3 | 2014 | 309 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 1110 | 0.110 |
Why?
|
| Cricetulus | 2 | 2015 | 810 | 0.110 |
Why?
|
| Electrocardiography | 5 | 2022 | 6409 | 0.110 |
Why?
|
| Jugular Veins | 1 | 2014 | 211 | 0.110 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2014 | 98 | 0.110 |
Why?
|
| Ischemic Postconditioning | 1 | 2013 | 24 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 678 | 0.110 |
Why?
|
| Cathepsin B | 1 | 2013 | 80 | 0.110 |
Why?
|
| Oximetry | 1 | 2016 | 462 | 0.100 |
Why?
|
| Female | 26 | 2024 | 396660 | 0.100 |
Why?
|
| Hypertension | 3 | 2022 | 8615 | 0.100 |
Why?
|
| CHO Cells | 2 | 2015 | 1376 | 0.100 |
Why?
|
| Mitochondria | 2 | 2017 | 3678 | 0.100 |
Why?
|
| Bone Regeneration | 1 | 2015 | 437 | 0.100 |
Why?
|
| Flow Cytometry | 3 | 2015 | 5891 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 301 | 0.100 |
Why?
|
| Nanomedicine | 1 | 2015 | 289 | 0.100 |
Why?
|
| Fibrosis | 3 | 2015 | 2078 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2015 | 730 | 0.100 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2012 | 139 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1895 | 0.100 |
Why?
|
| Biofeedback, Psychology | 1 | 2012 | 117 | 0.100 |
Why?
|
| Mice, Knockout | 12 | 2018 | 14476 | 0.100 |
Why?
|
| Cricetinae | 2 | 2015 | 2415 | 0.090 |
Why?
|
| Artifacts | 1 | 2020 | 1904 | 0.090 |
Why?
|
| Overweight | 1 | 2022 | 2448 | 0.090 |
Why?
|
| Arteriovenous Fistula | 1 | 2014 | 320 | 0.090 |
Why?
|
| Quinolines | 1 | 2017 | 770 | 0.090 |
Why?
|
| Chaperonin 60 | 1 | 2011 | 97 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3587 | 0.090 |
Why?
|
| Particle Size | 3 | 2015 | 1633 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2018 | 1407 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2016 | 5311 | 0.090 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 456 | 0.090 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.090 |
Why?
|
| Male | 25 | 2024 | 364203 | 0.090 |
Why?
|
| Cell Line | 3 | 2020 | 15567 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2015 | 702 | 0.090 |
Why?
|
| Action Potentials | 1 | 2018 | 1835 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2022 | 3561 | 0.090 |
Why?
|
| Heart Rupture, Post-Infarction | 2 | 2008 | 48 | 0.080 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2007 | 1233 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2013 | 505 | 0.080 |
Why?
|
| Antigens, Ly | 1 | 2010 | 297 | 0.080 |
Why?
|
| Hot Temperature | 1 | 2015 | 1441 | 0.080 |
Why?
|
| Ultrasonography | 4 | 2015 | 6000 | 0.080 |
Why?
|
| Leukocytosis | 1 | 2010 | 248 | 0.080 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 1987 | 0.080 |
Why?
|
| Inflammation | 6 | 2018 | 10869 | 0.080 |
Why?
|
| Heart-Lung Transplantation | 1 | 2009 | 87 | 0.080 |
Why?
|
| Bacteremia | 1 | 2015 | 983 | 0.080 |
Why?
|
| Metals | 1 | 2013 | 711 | 0.080 |
Why?
|
| Copper Radioisotopes | 2 | 2024 | 99 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2018 | 2926 | 0.070 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 1089 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22254 | 0.070 |
Why?
|
| Agar | 1 | 2007 | 51 | 0.070 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2011 | 588 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2009 | 384 | 0.070 |
Why?
|
| Lymphocytes | 1 | 2015 | 2605 | 0.070 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 428 | 0.070 |
Why?
|
| Cineradiography | 1 | 2007 | 23 | 0.070 |
Why?
|
| Movement | 1 | 2014 | 1473 | 0.070 |
Why?
|
| Lysosomes | 1 | 2013 | 937 | 0.070 |
Why?
|
| Myocardial Contraction | 3 | 2009 | 1516 | 0.070 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2007 | 139 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2015 | 5022 | 0.070 |
Why?
|
| Reference Values | 2 | 2017 | 4918 | 0.070 |
Why?
|
| Oxides | 1 | 2008 | 402 | 0.070 |
Why?
|
| Factor XIII Deficiency | 1 | 2006 | 16 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2020 | 3305 | 0.070 |
Why?
|
| Binding Sites | 2 | 2013 | 6014 | 0.070 |
Why?
|
| Vibration | 1 | 2008 | 334 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2015 | 23621 | 0.060 |
Why?
|
| Ferric Compounds | 1 | 2008 | 376 | 0.060 |
Why?
|
| Heptanoic Acids | 1 | 2008 | 344 | 0.060 |
Why?
|
| Cell Membrane | 2 | 2015 | 3642 | 0.060 |
Why?
|
| Wound Healing | 2 | 2008 | 2800 | 0.060 |
Why?
|
| Models, Statistical | 2 | 2012 | 5098 | 0.060 |
Why?
|
| Polymers | 1 | 2012 | 1624 | 0.060 |
Why?
|
| Peroxidase | 1 | 2008 | 610 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2563 | 0.060 |
Why?
|
| Swine | 3 | 2023 | 5987 | 0.060 |
Why?
|
| Reperfusion Injury | 1 | 2011 | 1043 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2006 | 342 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2014 | 4424 | 0.060 |
Why?
|
| Spleen | 1 | 2010 | 2292 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2008 | 1055 | 0.060 |
Why?
|
| Creatine Kinase | 1 | 2006 | 683 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2715 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2010 | 1515 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 7469 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3700 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 1337 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2008 | 771 | 0.050 |
Why?
|
| Integrin alphaVbeta3 | 2 | 2018 | 102 | 0.050 |
Why?
|
| Intercalating Agents | 2 | 2013 | 33 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15925 | 0.050 |
Why?
|
| Electricity | 1 | 2023 | 173 | 0.050 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2003 | 353 | 0.050 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2004 | 163 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2017 | 2275 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 877 | 0.050 |
Why?
|
| Lipids | 1 | 2013 | 3322 | 0.050 |
Why?
|
| Thromboembolism | 1 | 2008 | 1003 | 0.050 |
Why?
|
| Cardiotonic Agents | 2 | 2015 | 540 | 0.050 |
Why?
|
| Water | 1 | 2008 | 1419 | 0.050 |
Why?
|
| Organic Chemicals | 2 | 2013 | 211 | 0.050 |
Why?
|
| Pyrroles | 1 | 2008 | 1122 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 2144 | 0.050 |
Why?
|
| Rupture, Spontaneous | 1 | 2002 | 365 | 0.050 |
Why?
|
| Biosensing Techniques | 1 | 2007 | 641 | 0.050 |
Why?
|
| Acute Disease | 1 | 2011 | 7236 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2010 | 9551 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2011 | 2906 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2007 | 1285 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2011 | 3076 | 0.040 |
Why?
|
| Scattering, Radiation | 2 | 2015 | 486 | 0.040 |
Why?
|
| Leukocytes | 1 | 2007 | 2034 | 0.040 |
Why?
|
| Forecasting | 1 | 2008 | 2936 | 0.040 |
Why?
|
| Cell Movement | 1 | 2010 | 5203 | 0.040 |
Why?
|
| Stroke Volume | 4 | 2018 | 5618 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2008 | 2079 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2004 | 761 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 17097 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 8108 | 0.040 |
Why?
|
| Xenobiotics | 1 | 2018 | 71 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9532 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2698 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 3834 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1754 | 0.040 |
Why?
|
| Apolipoproteins E | 3 | 2007 | 1459 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3468 | 0.030 |
Why?
|
| Time Factors | 3 | 2014 | 40154 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 30238 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2019 | 591 | 0.030 |
Why?
|
| Renal Artery | 1 | 2017 | 355 | 0.030 |
Why?
|
| Papio | 1 | 2017 | 672 | 0.030 |
Why?
|
| Microvessels | 1 | 2020 | 585 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2020 | 65295 | 0.030 |
Why?
|
| Adult | 8 | 2022 | 223317 | 0.030 |
Why?
|
| Carbanilides | 1 | 2014 | 18 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2019 | 3139 | 0.030 |
Why?
|
| Isoproterenol | 1 | 2015 | 398 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2472 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 29963 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 627 | 0.030 |
Why?
|
| Neointima | 1 | 2014 | 133 | 0.030 |
Why?
|
| Radioisotopes | 1 | 2015 | 509 | 0.030 |
Why?
|
| Macrophage Activation | 2 | 2007 | 554 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2014 | 113 | 0.030 |
Why?
|
| Dimerization | 1 | 2015 | 882 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2012 | 12 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 26396 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2010 | 7868 | 0.030 |
Why?
|
| Disulfides | 1 | 2015 | 462 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 685 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2013 | 187 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2018 | 4167 | 0.030 |
Why?
|
| Bleomycin | 1 | 2013 | 492 | 0.030 |
Why?
|
| Gene Expression | 2 | 2019 | 7587 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 616 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 2012 | 238 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 719 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2014 | 1889 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 3052 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2018 | 1182 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 2478 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2013 | 250 | 0.020 |
Why?
|
| Systole | 1 | 2014 | 935 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2021 | 6260 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2014 | 1150 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10455 | 0.020 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2011 | 75 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1479 | 0.020 |
Why?
|
| Random Allocation | 1 | 2015 | 2394 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 2014 | 772 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 1104 | 0.020 |
Why?
|
| Whole Body Imaging | 1 | 2013 | 283 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 2012 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 1374 | 0.020 |
Why?
|
| Heart Injuries | 1 | 2012 | 207 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2217 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2004 | 2787 | 0.020 |
Why?
|
| Ion Channels | 1 | 2015 | 1043 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2012 | 661 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 14098 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2014 | 1208 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 1673 | 0.020 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2010 | 153 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 282 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 980 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 2009 | 175 | 0.020 |
Why?
|
| Light | 1 | 2015 | 1358 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 74886 | 0.020 |
Why?
|
| Enalapril | 1 | 2010 | 317 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9464 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2018 | 2056 | 0.020 |
Why?
|
| Caspases | 1 | 2011 | 881 | 0.020 |
Why?
|
| Dalteparin | 1 | 2008 | 44 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2013 | 1741 | 0.020 |
Why?
|
| Ventricular Function | 1 | 2009 | 404 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 521 | 0.020 |
Why?
|
| Homeostasis | 1 | 2018 | 3345 | 0.020 |
Why?
|
| Iopamidol | 1 | 2007 | 188 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 2616 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 3618 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2007 | 439 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2007 | 281 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2457 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2006 | 110 | 0.020 |
Why?
|
| Ligation | 1 | 2007 | 446 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1606 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 1646 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2004 | 5180 | 0.020 |
Why?
|
| Injections | 1 | 2008 | 839 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 1882 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 12986 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3608 | 0.010 |
Why?
|
| Neutrophil Infiltration | 1 | 2007 | 393 | 0.010 |
Why?
|
| Body Weight | 1 | 2015 | 4627 | 0.010 |
Why?
|
| Perfusion | 1 | 2009 | 1409 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2006 | 391 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2015 | 8310 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81659 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 1292 | 0.010 |
Why?
|
| Middle Aged | 6 | 2020 | 223233 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 11923 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 661 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 740 | 0.010 |
Why?
|
| Optics and Photonics | 1 | 2004 | 305 | 0.010 |
Why?
|
| Heart Rate | 1 | 2014 | 4209 | 0.010 |
Why?
|
| Cell Survival | 1 | 2012 | 5750 | 0.010 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.010 |
Why?
|
| Capillaries | 1 | 2006 | 755 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10092 | 0.010 |
Why?
|
| Young Adult | 2 | 2022 | 59980 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7063 | 0.010 |
Why?
|
| Abdomen | 1 | 2008 | 1138 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 13650 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 832 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 1612 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2007 | 1145 | 0.010 |
Why?
|
| Camptothecin | 1 | 2004 | 599 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2006 | 963 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 1144 | 0.010 |
Why?
|
| Video Recording | 1 | 2005 | 977 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 3273 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2006 | 3093 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2015 | 8531 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 2931 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6331 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8729 | 0.010 |
Why?
|
| Cytokines | 1 | 2014 | 7446 | 0.010 |
Why?
|
| Aged | 4 | 2018 | 171319 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18989 | 0.010 |
Why?
|
| Calcinosis | 1 | 2007 | 1481 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2007 | 4032 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 3618 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 2627 | 0.010 |
Why?
|
| Radiography | 1 | 2007 | 6975 | 0.010 |
Why?
|
| Neoplasms | 1 | 2005 | 22350 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3511 | 0.010 |
Why?
|
| Graft Rejection | 1 | 2009 | 4498 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13411 | 0.010 |
Why?
|
| Peptides | 1 | 2006 | 4348 | 0.010 |
Why?
|
| Calcium | 1 | 2007 | 5792 | 0.010 |
Why?
|
| Neutrophils | 1 | 2006 | 3779 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 6966 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10748 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9327 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2008 | 4854 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 54886 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2008 | 24299 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2007 | 59548 | 0.000 |
Why?
|
| Adolescent | 1 | 2004 | 89046 | 0.000 |
Why?
|